» Articles » PMID: 33613150

3D Bioprinting Using UNIversal Orthogonal Network (UNION) Bioinks

Overview
Journal Adv Funct Mater
Date 2021 Feb 22
PMID 33613150
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Three-dimensional (3D) bioprinting is a promising technology to produce tissue-like structures, but a lack of diversity in bioinks is a major limitation. Ideally each cell type would be printed in its own customizable bioink. To fulfill this need for a universally applicable bioink strategy, we developed a versatile, bioorthogonal bioink crosslinking mechanism that is cell compatible and works with a range of polymers. We term this family of materials UNIversal, Orthogonal Network (UNION) bioinks. As demonstration of UNION bioink versatility, gelatin, hyaluronic acid (HA), recombinant elastin-like protein (ELP), and polyethylene glycol (PEG) were each used as backbone polymers to create inks with storage moduli spanning 200 to 10,000 Pa. Because UNION bioinks are crosslinked by a common chemistry, multiple materials can be printed together to form a unified, cohesive structure. This approach is compatible with any support bath that enables diffusion of UNION crosslinkers. Both matrix-adherent human corneal mesenchymal stromal cells and non-matrix-adherent human induced pluripotent stem cell-derived neural progenitor spheroids were printed with UNION bioinks. The cells retained high viability and expressed characteristic phenotypic markers after printing. Thus, UNION bioinks are a versatile strategy to expand the toolkit of customizable materials available for 3D bioprinting.

Citing Articles

Spontaneous Self-Organized Order Emerging From Intrinsically Disordered Protein Polymers.

Acosta S, Rodriguez-Alonso P, Chaskovska V, Fernandez-Fernandez J, Rodriguez-Cabello J Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2025; 17(1):e70003.

PMID: 39950263 PMC: 11826379. DOI: 10.1002/wnan.70003.


Advanced bioengineering strategies broaden the therapeutic landscape for corneal failure.

Al Monla R, Daien V, Michon F Front Bioeng Biotechnol. 2024; 12:1480772.

PMID: 39605752 PMC: 11598527. DOI: 10.3389/fbioe.2024.1480772.


Dissecting the Interplay Mechanism among Process Parameters toward the Biofabrication of High-Quality Shapes in Embedded Bioprinting.

Wu Y, Yang X, Gupta D, Alioglu M, Qin M, Ozbolat V Adv Funct Mater. 2024; 34(21).

PMID: 38952568 PMC: 11216718. DOI: 10.1002/adfm.202313088.


Contribution of the ELRs to the development of advanced models.

Puertas-Bartolome M, Venegas-Bustos D, Acosta S, Rodriguez-Cabello J Front Bioeng Biotechnol. 2024; 12:1363865.

PMID: 38650751 PMC: 11033926. DOI: 10.3389/fbioe.2024.1363865.


Gelation of Uniform Interfacial Diffusant in Embedded 3D Printing.

Shin S, Brunel L, Cai B, Kilian D, Roth J, Seymour A Adv Funct Mater. 2024; 33(50).

PMID: 38646474 PMC: 11031202. DOI: 10.1002/adfm.202307435.


References
1.
Duarte Campos D, Lindsay C, Roth J, LeSavage B, Seymour A, Krajina B . Bioprinting Cell- and Spheroid-Laden Protein-Engineered Hydrogels as Tissue-on-Chip Platforms. Front Bioeng Biotechnol. 2020; 8:374. PMC: 7198818. DOI: 10.3389/fbioe.2020.00374. View

2.
Madl C, Heilshorn S . Bioorthogonal Strategies for Engineering Extracellular Matrices. Adv Funct Mater. 2019; 28(11). PMC: 6761700. DOI: 10.1002/adfm.201706046. View

3.
Boontheekul T, Hill E, Kong H, Mooney D . Regulating myoblast phenotype through controlled gel stiffness and degradation. Tissue Eng. 2007; 13(7):1431-42. DOI: 10.1089/ten.2006.0356. View

4.
Murphy S, Atala A . 3D bioprinting of tissues and organs. Nat Biotechnol. 2014; 32(8):773-85. DOI: 10.1038/nbt.2958. View

5.
Compaan A, Song K, Huang Y . Gellan Fluid Gel as a Versatile Support Bath Material for Fluid Extrusion Bioprinting. ACS Appl Mater Interfaces. 2019; 11(6):5714-5726. DOI: 10.1021/acsami.8b13792. View